vs

Side-by-side financial comparison of PHINIA INC. (PHIN) and Steris (STE). Click either name above to swap in a different company.

Steris is the larger business by last-quarter revenue ($1.5B vs $889.0M, roughly 1.7× PHINIA INC.). On growth, Steris posted the faster year-over-year revenue change (9.2% vs 6.7%). Steris produced more free cash flow last quarter ($199.5M vs $67.0M). Over the past eight quarters, Steris's revenue compounded faster (15.8% CAGR vs 1.5%).

PHINIA Inc. is a global automotive technology provider specializing in fuel injection systems, starters, alternators, and hybrid/electric vehicle components. It serves OEMs and aftermarket customers across North America, Europe, Asia Pacific and key markets, covering passenger car, commercial vehicle and industrial mobility segments.

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

PHIN vs STE — Head-to-Head

Bigger by revenue
STE
STE
1.7× larger
STE
$1.5B
$889.0M
PHIN
Growing faster (revenue YoY)
STE
STE
+2.4% gap
STE
9.2%
6.7%
PHIN
More free cash flow
STE
STE
$132.5M more FCF
STE
$199.5M
$67.0M
PHIN
Faster 2-yr revenue CAGR
STE
STE
Annualised
STE
15.8%
1.5%
PHIN

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
PHIN
PHIN
STE
STE
Revenue
$889.0M
$1.5B
Net Profit
$192.9M
Gross Margin
21.7%
43.8%
Operating Margin
7.8%
18.3%
Net Margin
12.9%
Revenue YoY
6.7%
9.2%
Net Profit YoY
11.2%
EPS (diluted)
$1.14
$1.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PHIN
PHIN
STE
STE
Q4 25
$889.0M
$1.5B
Q3 25
$908.0M
$1.5B
Q2 25
$890.0M
$1.4B
Q1 25
$796.0M
$1.5B
Q4 24
$833.0M
$1.4B
Q3 24
$839.0M
$1.3B
Q2 24
$868.0M
$1.3B
Q1 24
$863.0M
$1.1B
Net Profit
PHIN
PHIN
STE
STE
Q4 25
$192.9M
Q3 25
$13.0M
$191.9M
Q2 25
$46.0M
$177.4M
Q1 25
$26.0M
$145.7M
Q4 24
$173.5M
Q3 24
$31.0M
$150.0M
Q2 24
$14.0M
$145.4M
Q1 24
$29.0M
$-1.4M
Gross Margin
PHIN
PHIN
STE
STE
Q4 25
21.7%
43.8%
Q3 25
22.0%
44.2%
Q2 25
22.1%
45.1%
Q1 25
21.6%
43.3%
Q4 24
22.7%
44.5%
Q3 24
22.3%
43.6%
Q2 24
21.7%
44.7%
Q1 24
22.2%
40.2%
Operating Margin
PHIN
PHIN
STE
STE
Q4 25
7.8%
18.3%
Q3 25
3.7%
18.2%
Q2 25
10.0%
17.7%
Q1 25
7.8%
14.6%
Q4 24
6.1%
17.9%
Q3 24
7.9%
16.5%
Q2 24
8.2%
14.5%
Q1 24
8.2%
22.0%
Net Margin
PHIN
PHIN
STE
STE
Q4 25
12.9%
Q3 25
1.4%
13.1%
Q2 25
5.2%
12.8%
Q1 25
3.3%
9.8%
Q4 24
12.7%
Q3 24
3.7%
11.3%
Q2 24
1.6%
11.4%
Q1 24
3.4%
-0.1%
EPS (diluted)
PHIN
PHIN
STE
STE
Q4 25
$1.14
$1.96
Q3 25
$0.33
$1.94
Q2 25
$1.14
$1.79
Q1 25
$0.63
$1.48
Q4 24
$0.13
$1.75
Q3 24
$0.70
$1.51
Q2 24
$0.31
$1.46
Q1 24
$0.62
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PHIN
PHIN
STE
STE
Cash + ST InvestmentsLiquidity on hand
$359.0M
$423.7M
Total DebtLower is stronger
$970.0M
$1.9B
Stockholders' EquityBook value
$1.6B
$7.2B
Total Assets
$3.8B
$10.6B
Debt / EquityLower = less leverage
0.61×
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PHIN
PHIN
STE
STE
Q4 25
$359.0M
$423.7M
Q3 25
$349.0M
$319.2M
Q2 25
$347.0M
$279.7M
Q1 25
$373.0M
$171.7M
Q4 24
$484.0M
$155.2M
Q3 24
$477.0M
$172.2M
Q2 24
$339.0M
$198.3M
Q1 24
$325.0M
$207.0M
Total Debt
PHIN
PHIN
STE
STE
Q4 25
$970.0M
$1.9B
Q3 25
$990.0M
$1.9B
Q2 25
$990.0M
$1.9B
Q1 25
$989.0M
$1.9B
Q4 24
$988.0M
$2.0B
Q3 24
$987.0M
$2.2B
Q2 24
$821.0M
$2.2B
Q1 24
$706.0M
$3.1B
Stockholders' Equity
PHIN
PHIN
STE
STE
Q4 25
$1.6B
$7.2B
Q3 25
$1.6B
$7.0B
Q2 25
$1.6B
$7.0B
Q1 25
$1.5B
$6.6B
Q4 24
$1.6B
$6.4B
Q3 24
$1.7B
$6.6B
Q2 24
$1.7B
$6.4B
Q1 24
$1.9B
$6.3B
Total Assets
PHIN
PHIN
STE
STE
Q4 25
$3.8B
$10.6B
Q3 25
$4.0B
$10.4B
Q2 25
$3.9B
$10.4B
Q1 25
$3.7B
$10.1B
Q4 24
$3.8B
$10.0B
Q3 24
$4.0B
$10.2B
Q2 24
$3.9B
$10.1B
Q1 24
$4.0B
$11.1B
Debt / Equity
PHIN
PHIN
STE
STE
Q4 25
0.61×
0.27×
Q3 25
0.62×
0.27×
Q2 25
0.61×
0.27×
Q1 25
0.64×
0.29×
Q4 24
0.63×
0.32×
Q3 24
0.58×
0.33×
Q2 24
0.47×
0.35×
Q1 24
0.38×
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PHIN
PHIN
STE
STE
Operating Cash FlowLast quarter
$96.0M
$298.2M
Free Cash FlowOCF − Capex
$67.0M
$199.5M
FCF MarginFCF / Revenue
7.5%
13.3%
Capex IntensityCapex / Revenue
3.3%
6.6%
Cash ConversionOCF / Net Profit
1.55×
TTM Free Cash FlowTrailing 4 quarters
$188.0M
$917.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PHIN
PHIN
STE
STE
Q4 25
$96.0M
$298.2M
Q3 25
$119.0M
$287.8M
Q2 25
$57.0M
$420.0M
Q1 25
$40.0M
$260.8M
Q4 24
$73.0M
$332.8M
Q3 24
$95.0M
$250.7M
Q2 24
$109.0M
$303.7M
Q1 24
$31.0M
$254.8M
Free Cash Flow
PHIN
PHIN
STE
STE
Q4 25
$67.0M
$199.5M
Q3 25
$93.0M
$201.3M
Q2 25
$23.0M
$326.4M
Q1 25
$5.0M
$189.9M
Q4 24
$53.0M
$243.6M
Q3 24
$70.0M
$148.8M
Q2 24
$92.0M
$195.7M
Q1 24
$-12.0M
$163.3M
FCF Margin
PHIN
PHIN
STE
STE
Q4 25
7.5%
13.3%
Q3 25
10.2%
13.8%
Q2 25
2.6%
23.5%
Q1 25
0.6%
12.8%
Q4 24
6.4%
17.8%
Q3 24
8.3%
11.2%
Q2 24
10.6%
15.3%
Q1 24
-1.4%
14.6%
Capex Intensity
PHIN
PHIN
STE
STE
Q4 25
3.3%
6.6%
Q3 25
2.9%
5.9%
Q2 25
3.8%
6.7%
Q1 25
4.4%
4.8%
Q4 24
2.4%
6.5%
Q3 24
3.0%
7.7%
Q2 24
2.0%
8.4%
Q1 24
5.0%
8.2%
Cash Conversion
PHIN
PHIN
STE
STE
Q4 25
1.55×
Q3 25
9.15×
1.50×
Q2 25
1.24×
2.37×
Q1 25
1.54×
1.79×
Q4 24
1.92×
Q3 24
3.06×
1.67×
Q2 24
7.79×
2.09×
Q1 24
1.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PHIN
PHIN

Customer$618.0M70%
Fuel Systems$194.0M22%
Other$77.0M9%

STE
STE

Servicerevenues$404.7M27%
Consumablerevenues$387.1M26%
Applied Sterilization Technologies$286.6M19%
Capitalequipmentrevenues$272.1M18%
Life Science$145.8M10%

Related Comparisons